M1238 Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
Short descriptor: Doc 2nd recom hzv 2-6 mo int
Look up M1238 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
M1238 is the HCPCS Level II code for Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31) (2026). It belongs to Section M — Medical Services. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.
Classification & CMS Attributes
- Section
- M: Medical Services
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Not separately priced by Part B (indicator 00)
- Type of Service
- Medical care
- Effective Date
- 2024-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference M1238 with the canonical source and edition:
M1238 — Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31). ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/M1238
Canonical URL: https://icd10codingpro.com/hcpcs-codes/M1238